regn stock forecast zacks

The average surprise for the last two quarters was 2224. Get a real-time Regeneron Pharmaceuticals Inc.

Regeneron Regn Q1 Earnings And Revenues Beat Estimates Nasdaq

Their forecasts range from 57500 to 85000.

. What You Should Know. For the last reported quarter Regeneron came out with earnings of 836 per share versus the Zacks Consensus Estimate of 723 per share representing a surprise of 1563. Analysts forecast that Regeneron Pharmaceuticals Inc.

Zacks Zacks is the leading investment research firm focusing on stock research analysis and recommendations. Furthermore the long-term growth rate is currently an impressive 163 suggesting pretty good. According to Zacks analysts expect that Regeneron Pharmaceuticals will report full-year sales of 1170 billion for the current financial.

In 1978 our founder discovered the power of earnings estimate revisions to enable. One stock to keep an eye on is Regeneron REGN. In fact the current growth estimate for this year calls for earnings-per-share growth of 900.

The average twelve-month price target for Regeneron Pharmaceuticals is 72633 with a high price target of 85000 and a low price target of 57500. This suggests a possible upside of 125 from the stocks current price. Zacks Zacks is the leading investment research firm focusing on stock research analysis and recommendations.

Low estimate 849 801. Five analysts have issued estimates for Regeneron Pharmaceuticals earnings with estimates ranging from 255 billion to 283 billion. For the first quarter Regeneron earnings of 660 per share on an adjusted basis climbed 48 year over year and crushed the average estimate of analysts polled by Zacks Investment Research for.

Zacks proprietary data indicates that regeneron pharmaceuticals inc. Regn Stock Forecast Zacks - Regeneron Regn Falls More Than Broader Markets What You Need To Know Business News - Forward dividend yield na. Regeneron Pharmaceuticals REGN Quote Overview Zacks Research Regeneron Pharmaceuticals REGN Style Scores Trades from 1.

0950pm Tuesday 15th Mar 2022 Zacks Investment Research. Regeneron REGN Quick Quote REGN - Free Report is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended June 2020This widely. Pe ratio ttm is a widely used stock.

We also note that REGN holds a PEG ratio of 128. High estimate 990 1004. You can see the complete list of todays Zacks 1 Rank Strong Buy stocks here.

Real time Regeneron Pharmaceuticals REGN stock price quote stock graph news analysis. For the next year analysts forecast that the business will post earnings of 4720 per share with EPS estimates ranging from 4068 to 5552. Zacks Investment Researchs earnings per share averages are a mean average based on a survey of research firms that that provide coverage for Regeneron Pharmaceuticals.

NASDAQREGN - Get Rating will announce 271 billion in sales for the current quarter Zacks reports. Earnings per share. Regeneron REGN Gains But Lags Market.

Learn more on REGNs analyst rating history. For the last reported quarter Regeneron came out with earnings of 2580 per share versus the Zacks Consensus Estimate of 1955 per. On average they anticipate Regeneron Pharmaceuticals stock price to reach 72633 in the next twelve months.

One stock to keep an eye on is Regeneron REGN. Regeneron currently has a Zacks Rank 2 Buy. The company detailed out the first meaningful revenue forecast in its.

In 1978 our founder discovered the power of earnings estimate revisions to enable. REGN stock price quote with breaking news financials statistics charts and more. For the Regeneron Pharmaceuticals Inc.

Find real-time REGN - Regeneron Pharmaceuticals Inc stock quotes company profile news and forecasts from CNN Business. Most recent consensus 939 925. The average rating for REGN stock is Buy The 12-month stock price forecast is 71609 which is an increase of 1093 from the latest price.

REGN is currently sporting a Zacks Rank of 2 Buy and an A for Value. REGN is currently sporting a Zacks Rank of 2 Buy and an A for Value. Regeneron REGN closed the most recent trading day at 66593 moving 145 from the previous trading session.

5 Must Buy Stocks For Q4 With Strong Growth Potential Nasdaq